Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Development of daptomycin for gram-positive infections.
Tally FP, DeBruin MF. Tally FP, et al. J Antimicrob Chemother. 2000 Oct;46(4):523-6. doi: 10.1093/jac/46.4.523. J Antimicrob Chemother. 2000. PMID: 11020247 Review. No abstract available.
Effectiveness and duration of daptomycin therapy in resolving clinical symptoms in the treatment of complicated skin and skin structure infections.
Krige JE, Lindfield K, Friedrich L, Otradovec C, Martone WJ, Katz DE, Tally F. Krige JE, et al. Curr Med Res Opin. 2007 Sep;23(9):2147-56. doi: 10.1185/030079907X219652. Curr Med Res Opin. 2007. PMID: 17669231 Clinical Trial.
A survey of Bacteroides susceptibility in the United States.
Cuchural G, Jacobus N, Gorbach SL, Tally FP. Cuchural G, et al. J Antimicrob Chemother. 1981 Dec;8 Suppl D:27-31. doi: 10.1093/jac/8.suppl_d.27. J Antimicrob Chemother. 1981. PMID: 7338488 No abstract available.
In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
Testa RT, Petersen PJ, Jacobus NV, Sum PE, Lee VJ, Tally FP. Testa RT, et al. Antimicrob Agents Chemother. 1993 Nov;37(11):2270-7. doi: 10.1128/aac.37.11.2270. Antimicrob Agents Chemother. 1993. PMID: 8285606 Free PMC article.
Safety profile of piperacillin/tazobactam in phase I and III clinical studies.
Kuye O, Teal J, DeVries VG, Morrow CA, Tally FP. Kuye O, et al. J Antimicrob Chemother. 1993 Jan;31 Suppl A:113-24. doi: 10.1093/jac/31.suppl_a.113. J Antimicrob Chemother. 1993. PMID: 8383652 Clinical Trial.
Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines.
Rasmussen BA, Gluzman Y, Tally FP. Rasmussen BA, et al. Antimicrob Agents Chemother. 1994 Jul;38(7):1658-60. doi: 10.1128/aac.38.7.1658. Antimicrob Agents Chemother. 1994. PMID: 7526784 Free PMC article.
Penetration of clindamycin into experimental infections with Bacteroides fragilis.
Simon GL, Richmond DM, Tally FP, Barza M, Gorbach SL. Simon GL, et al. J Antimicrob Chemother. 1981 Jul;8(1):59-64. doi: 10.1093/jac/8.1.59. J Antimicrob Chemother. 1981. PMID: 7251540 No abstract available.
Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities.
Snydman DR, Tally FP, Knuppel R, Landrigan J, Gorbach SL, Bartlett JG. Snydman DR, et al. J Antimicrob Chemother. 1980 Jul;6(4):519-25. doi: 10.1093/jac/6.4.519. J Antimicrob Chemother. 1980. PMID: 6968748 No abstract available.
Factors affecting the choice of antimicrobial therapy for anaerobic infection.
Cuchural G, Tally FP. Cuchural G, et al. J Antimicrob Chemother. 1982 Aug;10 Suppl A:11-22. doi: 10.1093/jac/10.suppl_a.11. J Antimicrob Chemother. 1982. PMID: 6749791 Review. No abstract available.
Susceptibility of anaerobic bacteria to Sch 34343 and other beta-lactam antibiotics.
Jacobus NV, Tally FP, Gorbach SL. Jacobus NV, et al. J Antimicrob Chemother. 1985 Jun;15 Suppl C:189-91. doi: 10.1093/jac/15.suppl_c.189. J Antimicrob Chemother. 1985. PMID: 4030547
127 results
Jump to page
Feedback